Air Liquide, FR0000120073

Air Liquide stock: UK watchdog raises concerns over Vivisol deal

Published on 11/21/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Air Liquide stock faces a UK competition review over Vivisol's planned purchase of its home-oxygen business. Remedies are due by November 26.

UK review puts deal in focus

  • The CMA said on November 19 that Vivisol's planned purchase of Air Liquide Healthcare's UK home-oxygen business may weaken competition.
  • The companies have until November 26 to offer remedies and avoid a deeper Phase 2 investigation.
  • Air Liquide stock remained in focus during a week that also brought fresh analyst commentary.
Air Liquide, FR0000120073, Illustration mit AI erstellt.

Air Liquide faced a new regulatory hurdle this week after the UK's Competition and Markets Authority raised concerns about Vivisol's planned purchase of Air Liquide Healthcare's home-oxygen services business. The CMA's position was reported on Thursday, November 19, by AJ Bell.

Competition concerns shape transaction outlook

The authority concluded its Phase 1 review by saying the potential acquisition may result in a substantial lessening of competition in one or more UK markets. Vivisol, the trading name of Dolby Medical Home Respiratory Care, and Air Liquide Healthcare both provide home-oxygen services to National Health Service patients.

Vivisol is a subsidiary of Italy-based Sol and holds four regional NHS home-oxygen contracts serving 20,000 patients, according to the report. The transaction's financial terms have not been disclosed.

Remedy deadline arrives next week

The companies have until Thursday, November 26, to offer remedies addressing the CMA's concerns. If the proposals are not accepted, the authority may refer the transaction to a deeper Phase 2 investigation.

That process creates a near-term regulatory milestone for Air Liquide's healthcare operations in the UK. The review does not by itself terminate the proposed transaction, but it places the parties under pressure to resolve the competition issues before the deadline.

Share price remains in investor focus

Air Liquide stock traded at 185.95 euros on Lang & Schwarz at 11:15 CET on Saturday, November 21.

Air Liquide company facts

  • Company: Air Liquide S.A.
  • ISIN: FR0000120073
  • Latest quote: 185.95 euros on Lang & Schwarz, November 21, 2026, 11:15 CET

Broader French equities can be followed in the Current market reports.

More news and analyses on Air Liquide stock.

Disclaimer...
en | FR0000120073 | AIR LIQUIDE | boerse | 70542016 | bgmi